| scholarly article | Q13442814 |
| P50 | author | W. Mark Saltzman | Q23092145 |
| Laura G Bracaglia | Q57140062 | ||
| Catherine B Xie | Q59540080 | ||
| Susann Spindler | Q90132477 | ||
| P2093 | author name string | Jordan S Pober | |
| George Tellides | |||
| Guangxin Li | |||
| Thomas D Manes | |||
| Francesc Lopez-Giraldez | |||
| Nancy Kirkiles-Smith | |||
| Jonathan Merola | |||
| Lingfeng Qin | |||
| Gregory T Tietjen | |||
| Richard W Pierce | |||
| Melanie Reschke | |||
| Tania Baltazar | |||
| P2860 | cites work | Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation | Q24627354 |
| Human induced pluripotent stem cells develop teratoma more efficiently and faster than human embryonic stem cells regardless the site of injection | Q24631810 | ||
| The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity | Q24651041 | ||
| TopHat: discovering splice junctions with RNA-Seq | Q24655505 | ||
| Participation of blood vessel cells in human adaptive immune responses | Q27021141 | ||
| Outgrowth endothelial cells: characterization and their potential for reversing ischemic retinopathy | Q28285524 | ||
| Circulating and tissue resident endothelial progenitor cells | Q28293322 | ||
| PVR (CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis | Q28298937 | ||
| Isolation of putative progenitor endothelial cells for angiogenesis | Q28302884 | ||
| Controlling the false discovery rate in behavior genetics research | Q29614833 | ||
| Approach to the Highly Sensitized Kidney Transplant Candidate | Q30277267 | ||
| Development and function of human innate immune cells in a humanized mouse model | Q33596915 | ||
| T-cell receptor-negative natural killer cells display antigen-specific cytotoxicity for microvascular endothelial cells | Q33782517 | ||
| Human umbilical cord mesenchymal stem cells derived from Wharton's jelly differentiate into insulin-producing cells in vitro | Q33956028 | ||
| Host myeloid cells are necessary for creating bioengineered human vascular networks in vivo. | Q34163217 | ||
| Differentiation of human pluripotent stem cells to cells similar to cord-blood endothelial colony-forming cells | Q34443020 | ||
| Efficient gene disruption in cultured primary human endothelial cells by CRISPR/Cas9. | Q34474978 | ||
| Efficient ablation of genes in human hematopoietic stem and effector cells using CRISPR/Cas9 | Q34727851 | ||
| CD4 T cell-mediated cardiac allograft rejection requires donor but not host MHC class II. | Q35127578 | ||
| Cytokine therapy reverses NK cell anergy in MHC-deficient tumors | Q35140125 | ||
| In vivo formation of complex microvessels lined by human endothelial cells in an immunodeficient mouse | Q35199743 | ||
| Induction of erythropoiesis using human vascular networks genetically engineered for controlled erythropoietin release | Q35553300 | ||
| Sublytic concentrations of the membrane attack complex of complement induce endothelial interleukin-8 and monocyte chemoattractant protein-1 through nuclear factor-kappa B activation | Q35764786 | ||
| Generation of murine tumor cell lines deficient in MHC molecule surface expression using the CRISPR/Cas9 system | Q36310789 | ||
| Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells | Q36346079 | ||
| Therapeutic effects of late outgrowth endothelial progenitor cells or mesenchymal stem cells derived from human umbilical cord blood on infarct repair | Q36395705 | ||
| Blocking MHC class II on human endothelium mitigates acute rejection | Q36588477 | ||
| Alloantibody and complement promote T cell-mediated cardiac allograft vasculopathy through noncanonical nuclear factor-κB signaling in endothelial cells. | Q37453921 | ||
| The pathology of chronic allograft dysfunction | Q37813404 | ||
| The promise of organ and tissue preservation to transform medicine | Q38673700 | ||
| The importance of non-HLA antibodies in transplantation | Q38877375 | ||
| Pretransplant frequency of donor-specific, IFN-gamma-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes. | Q40936737 | ||
| Complement C5 Inhibition Reduces T Cell-Mediated Allograft Vasculopathy Caused by Both Alloantibody and Ischemia Reperfusion Injury in Humanized Mice | Q41631576 | ||
| Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure | Q42171636 | ||
| The membrane attack complex of complement induces interleukin-8 and monocyte chemoattractant protein-1 secretion from human umbilical vein endothelial cells | Q42804319 | ||
| Human blood outgrowth endothelial cells improve islet survival and function when co-transplanted in a mouse model of diabetes | Q44141976 | ||
| Use of blood outgrowth endothelial cells for gene therapy for hemophilia A. | Q45882442 | ||
| Different regulatory and cytotoxic CD4+ T lymphocyte profiles in renal transplants with antibody-mediated chronic rejection or long-term good graft function. | Q46887236 | ||
| A p190BRhoGAP mutation and prolonged RhoB activation in fatal systemic capillary leak syndrome | Q47447773 | ||
| Transplanted late outgrowth endothelial progenitor cells as cell therapy product for stroke | Q48175406 | ||
| Organ Shortage: Can We Decrease the Demand? | Q48280899 | ||
| Liver transplantation--a vision realized. | Q48385516 | ||
| A New Treatment Option for Highly Sensitized Patients Awaiting Kidney Transplantation | Q49906190 | ||
| Tissue regeneration using endothelial colony-forming cells: promising cells for vascular repair | Q50068661 | ||
| Revisiting the specificity of the MHC class II transactivator CIITA in classical murine dendritic cells in vivo | Q50223277 | ||
| Alloimmunity to human endothelial cells derived from cord blood progenitors. | Q50859678 | ||
| Vascularization and engraftment of a human skin substitute using circulating progenitor cell-derived endothelial cells. | Q51171242 | ||
| Bcl-2 transduction protects human endothelial cell synthetic microvessel grafts from allogeneic T cells in vivo. | Q51629169 | ||
| Smooth muscle progenitor cells from peripheral blood promote the neovascularization of endothelial colony-forming cells. | Q51732730 | ||
| Human effector memory CD4+ T cells directly recognize allogeneic endothelial cells in vitro and in vivo. | Q51971439 | ||
| Pretransplant cellular alloimmunity as assessed by a panel of reactive T cells assay correlates with acute renal graft rejection. | Q51975758 | ||
| Late-outgrowth endothelial cells attenuate intimal hyperplasia contributed by mesenchymal stem cells after vascular injury. | Q53517346 | ||
| Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. | Q54432520 | ||
| Development of immunocompatible pluripotent stem cells via CRISPR-based human leukocyte antigen engineering | Q60919346 | ||
| EFFECT OF GRAFT PERFUSION WITH TWO CD45 MONOCLONAL ANTIBODIES ON INCIDENCE OF KIDNEY ALLOGRAFT REJECTION | Q61651760 | ||
| Human NKG2A overrides NKG2C effector functions to prevent autoreactivity of NK cells | Q62595268 | ||
| Heart transplantation | Q68952937 | ||
| Use of donor beta 2-microglobulin-deficient transgenic mouse liver cells for isografts, allografts, and xenografts | Q70665212 | ||
| Renal transplantation | Q72442105 | ||
| Human vascular endothelial cells stimulate memory but not naive CD8+ T cells to differentiate into CTL retaining an early activation phenotype | Q73755877 | ||
| Characterization of CD4(+) CTLs ex vivo | Q74145676 | ||
| Endothelial cell activation by sera containing HLA antibodies is mediated by interleukin-1 | Q77590810 | ||
| Human vascular endothelial cells favor clonal expansion of unusual alloreactive CTL | Q77841544 | ||
| The allogeneic response to cultured human skin equivalent in the hu-PBL-SCID mouse model of skin rejection | Q77988714 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 20 | |
| P921 | main subject | Cas9 | Q16965677 |
| CRISPR | Q412563 | ||
| CRISPR-Cas method | Q17310682 | ||
| P577 | publication date | 2019-10-17 | |
| P1433 | published in | JCI insight | Q27727187 |
| P1476 | title | Progenitor-derived human endothelial cells evade alloimmunity by CRISPR/Cas9-mediated complete ablation of MHC expression | |
| P478 | volume | 4 |
Search more.